7-OH, short for 7-hydroxymitragynine, is a potent opioid compound that occurs naturally in trace amounts in the kratom plant. The growing concern, however, is not primarily traditional kratom leaf. It is the increasing availability of concentrated and semi-synthetic 7-OH products sold as tablets, gummies, drink mixes, shots, and other products that may appear similar to herbal or wellness products.
The FDA has warned consumers that concentrated 7-OH products have potent opioid effects, have not been proven safe or effective for any medical use, and may carry significant risks, including misuse, physical dependence, and addiction. The agency specifically distinguishes these concentrated products from the trace amounts of 7-OH that occur naturally in kratom leaves.
Concern has grown enough to prompt federal action. In July 2026, the DEA announced its intent to temporarily place certain 7-OH substances Schedule 1 of the Controlled Substances Act, including 7-OH above a proposed concentration threshold and three related substances. The proposed action is specifically aimed at concentrated and synthetic 7-OH products and is not intended to apply to traditional botanical kratom containing only naturally occurring trace levels of 7-OH.
For individuals and families, that distinction matters. A product marketed alongside herbal supplements or sold at a gas station or smoke shop can still have powerful opioid activity and the potential for dependence. Understanding what 7-OH is, how concentrated products differ from traditional kratom, and what signs may indicate a developing problem can help people make more informed decisions about their health.
This guide explains what 7-OH hydroxymitragynine is, why concentrated forms are raising concern among federal health agencies, the potential effects and signs of dependence, what is currently known about 7-OH withdrawal, and when professional addiction treatment may be appropriate.
Quick Answer: Is 7‑OH Addictive?
7‑OH (7‑hydroxymitragynine) itself isn’t automatically “addictive” in every situation but concentrated 7‑OH products carry a real addiction risk. They act strongly on the brain’s opioid receptors, and when people use high‑potency tablets, gummies, or shots regularly, they can develop tolerance, cravings, and physical dependence. Over time, some users shift from occasional use to feeling they need 7‑OH just to function, which is the hallmark of a developing opioid‑type substance use disorder.
5 One‑Liner Key Takeaways
- 7‑OH is a potent opioid alkaloid that occurs naturally in tiny amounts in kratom, but new concentrated products can deliver much higher doses.
- Concentrated 7‑OH tablets, gummies, shots, and drink mixes are driving the addiction concern, not traditional kratom leaf used in normal ways.
- The DEA moved in July 2026 to temporarily schedule certain concentrated and synthetic 7‑OH substances because of their opioid activity and misuse risk.hpe+1
- Regular use of high‑potency 7‑OH can led to tolerance, physical dependence, withdrawal, and in some cases a full substance use disorder.
- If you’re needing 7‑OH to feel normal, can’t cut back, or get withdrawal when you skip a dose, that’s a signal to talk to a clinician or seek treatment.
What Is 7-OH Hydroxymitragynine?
7-hydroxymitragynine (7-OH) is a naturally occurring alkaloid found in very small amounts in the leaves of Mitragyna speciosa, the Southeast Asian tree commonly known as kratom. Kratom contains dozens of alkaloids, with mitragynine being the most abundant. Although naturally occurring 7-OH is present only in trace amounts, it is particularly significant because of its strong activity at the body’s opioid receptors.
Research has found that 7-OH interacts strongly with μ-opioid receptors, the same receptor system involved in the effects of traditional opioids. This opioid activity may produce effects such as:
- Pain relief
- Euphoria or a sense of well-being
- Sedation or relaxation
- Reduced alertness
- At higher exposures, potentially dangerous effects such as respiratory depression
An important distinction is that the 7-OH products now raising concern are not simply equivalent to traditional kratom leaves or powder. The FDA has warned that some commercially available products contain concentrated or enhanced levels of 7-OH that substantially exceed the amounts naturally present in kratom.
Concerns surrounding kratom and its active compounds are not entirely new. A study examining U.S. poison center data identified more than 3,400 kratom exposure calls between 2014 and 2019, demonstrating increasing reports involving kratom during that period. More recently, the FDA has specifically warned healthcare professionals and consumers about concentrated 7-hydroxymitragynine products because of their opioid activity and potential for misuse, dependence, and other serious harms.
Concentrated 7-OH Vs. Natural Kratom
Traditional kratom and concentrated 7-OH products are not the same. While 7-hydroxymitragynine occurs naturally in kratom, it is normally present only in very small amounts. The products currently raising concern contain substantially higher concentrations of 7-OH than would typically occur naturally in the plant.
This distinction matters because concentrating 7-OH can significantly increase a product’s opioid activity and potentially its risks. A tablet, gummy, shot, or other concentrated product marketed as “kratom” or plant-derived should not automatically be assumed to have the same composition or effects as traditional kratom leaf.
| Factors | Natural Kratom Leaf | Concentrated 7-OH Products |
| 7-OH Content | Trace amounts (<0.02% naturally occurring) | May contain substantially higher concentrations of 7-OH |
| Form | Traditionally consumed as leaf; also sold as powders, teas, or capsules | Commonly sold as tablets, gummies, shots, drink mixes, or other concentrated formulations |
| Potency | Mild to moderate | Significantly higher opioid-receptor activity |
| Onset of Effects | Varies by product, dose, and method of consumption | Varies considerably by formulation and route of administration |
| Dependence Risk | Regular kratom use can lead to tolerance, physical dependence, and withdrawal | Concentrated 7-OH raises particular concern because of its potent opioid activity and potential for misuse and dependence |
| Regulatory Status | Kratom itself is not federally scheduled, although state laws vary | Certain concentrated and synthetic 7-OH substances are the subject of the DEA’s 2026 temporary Schedule I scheduling process |
| Where It’s Sold | Specialty kratom/herbal retailers and online | Smoke shops, convenience stores, gas stations, specialty retailers, and online |
| Marketing | Often marketed as a botanical or herbal product | May be marketed as concentrated, enhanced, or more potent kratom-related products |
Why Is 7-Hydroxymitragynine So Potent?
One reason 7-hydroxymitragynine (7-OH) has raised concern is its strong activity at the body’s μ-opioid receptors, which are involved in pain relief, euphoria, sedation, physical dependence, and respiratory effects associated with opioid.
According to the FDA’s scientific assessment of 7-OH, laboratory and animal research indicates that 7-OH has potent opioid activity. Some preclinical studies have found 7-OH to produce effects at lower doses than morphine in specific experimental models. However, these findings should not be interpreted to mean that every 7-OH product is simply a certain number of times “stronger than morphine” in humans. Potency comparisons depend on what effect researchers are measuring, the dose, and the study model.
7-OH is also connected to mitragynine, the primary alkaloid found in kratom. Research indicates that the body can metabolize some mitragynine into 7-OH, which may contribute to kratom’s opioid-like effects.
The greater concern today is that 7-OH no longer has to be encountered only in the trace amounts naturally present in kratom. Concentrated 7-OH products can expose consumers to substantially higher amounts of this opioid-active compound, potentially increasing the risk of intoxication, tolerance, physical dependence, withdrawal, and other adverse effects.
Start Your Healing Journey Today
How Is 7-OH Sold, and Why Is It Called the “Gas Station Opioid”?
Part of the growing concern surrounding 7-OH is how easily concentrated products can be purchased. Unlike prescription opioids, which are dispensed through regulated healthcare settings, 7-OH products have been widely available at gas stations, smoke shops, convenience stores, specialty retailers, and online.
Concentrated 7-OH may be sold in forms such as tablets, gummies, drink shots, powders, and other flavored or brightly packaged products. Some are marketed using terms such as “kratom,” “plant-based,” or “natural,” which may lead consumers to underestimate their opioid activity or assume they carry the same risks as traditional botanical kratom.
This widespread retail availability has contributed to the nickname “gas station opioid.” Federal health officials have raised particular concerns about concentrated 7-OH products because consumers may be exposed to a potent opioid-active substance without the prescribing controls, standardized dosing, or medical supervision associated with pharmaceutical opioids.
FDA Commissioner Dr. Marty Makary has also publicly compared the potency of concentrated 7-OH with morphine while warning about its availability in products marketed directly to consumers. However, potency estimates vary depending on the study and effect being measured, so comparisons such as “13 times stronger than morphine” should not be interpreted as a universal measure of how every 7-OH product will affect a person.
The larger concern is straightforward: where a substance is sold does not determine how powerful or potentially addictive it is. A product available at a convenience store can still produce opioid effects, lead to physical dependence, and carry significant health risks.
Short-Term & Long-Term Effects of 7-OH
Because 7-OH acts on opioid receptors, concentrated products may produce opioid-like effects as well as potentially serious adverse reactions. The effects can vary depending on the amount used, product concentration, frequency of use, other substances taken at the same time, and individual health factors.
Research specifically examining the long-term effects of concentrated 7-OH in humans is still limited. However, its opioid activity and growing concerns about misuse and dependence have led federal health agencies to warn consumers about the potential risks of concentrated 7-OH products.
Short-Term Effects:
- Pain relief
- Euphoria or a sense of relaxation
- Sedation or drowsiness
- Nausea or gastrointestinal discomfort
- Sweating
- Dizziness or confusion
- Difficulty concentrating
- Changes in heart rate or blood pressure
- Slowed or shallow breathing, particularly at higher exposures or when combined with other substances
Long-Term Effects:
- Tolerance, where increasing amounts are needed to achieve the desired effect
- Physical dependence, where the body adapts to regular use
- Withdrawal symptoms when use is reduced or stopped
- Increasing cravings or preoccupation with obtaining and using 7-OH
- Sleep disturbances
- Continued use despite negative effects on health, relationships, work, or other responsibilities
- Substance use disorder or addiction
What We Have Seen:
People may begin using kratom or 7-OH for very different reasons. Some are looking for relief from physical discomfort, while others may use these products to cope with sleep difficulties, stress, anxiety, or other challenges. Over time, however, the reason for using can begin to change.
In our experience at Desert Willow Wellness, one of the most important warning signs is when someone is no longer using a substance primarily for the effect they originally wanted, but instead feels they need it to avoid withdrawal or simply feel normal. Their day may begin revolving around when they can take the next dose, whether they have enough available, or how they will obtain more.
That shift from wanting to use a substance to feeling like you need it can be an important indication of physical dependence or a developing substance use disorder. With products such as concentrated 7-OH, recognizing that change can be especially difficult when the product was originally perceived as “natural,” easily accessible, or less concerning than a traditional opioid.
What Are the Signs of 7-OH or Kratom Dependence?
Regular use of Kratom can lead to dependency, and concentrated 7-OH products may carry additional concerns because of their strong activity at opioid receptors. Research has found that 7-OH has approximately fivefold greater affinity for the μ-opioid receptor than mitragynine. However, this does not mean that everyone who uses 7-OH will become dependent.
Dependence can develop gradually, making the changes difficult to recognize at first. Signs may appear physically, behaviorally, and psychologically.
Physical Signs:
- Needing more of the product over time to achieve the same effect
- Experiencing withdrawal symptoms when a dose is reduced, delayed, or skipped
- Difficulty sleeping when not using 7-OH or kratom
- Fatigue or low energy between doses
- Gastrointestinal symptoms such as constipation or stomach discomfort
Behavioral Signs:
- Frequently purchasing or making trips to obtain 7-OH
- Keeping extra products available because of concern about running out
- Using 7-OH shortly after waking or repeatedly throughout the day
- Hiding or minimizing how much or how often you’re using
- Becoming increasingly preoccupied with obtaining the next dose
- Continuing to use despite problems with work, relationships, health, or other responsibilities
Psychological signs:
- Frequently thinking about when you can use 7-OH again
- Relying on it to cope with stress, anxiety, emotional discomfort, or other difficult feelings
- Trying to cut back or stop but finding it difficult to do so
- Feeling unable to function normally without it
- Experiencing strong cravings or urges to use
- Spending increasing amounts of time thinking about, obtaining, or using the product
7-OH Withdrawal Symptoms & Detox Timeline
A found that 7-OH demonstrated substantially greater binding affinity than mitragynine at several opioid receptors, including the μ-opioid receptor. Because of its opioid activity, regular use of concentrated 7-OH may lead to physical dependence, and reducing or stopping use can result in 7-OH withdrawal.
Potential withdrawal symptoms may include:
- Anxiety and restlessness
- Muscle aches and physical discomfort
- Sweating or chills
- Nausea, diarrhea, or stomach discomfort
- Difficulty sleeping
- Strong cravings
- Irritability or mood changes
- Low mood or difficulty concentrating
The General Timeline:
There is not yet a well-established, universal withdrawal timeline specifically for concentrated 7-OH products. Symptoms and duration can vary depending on the amount and frequency of use, how long someone has been using the product, individual health factors, and whether other substances are involved.
| Stage | Timing | What Happens |
| Early Withdrawal | Within the first day after reducing or stopping use | Restlessness, anxiety, sweating, cravings, sleep difficulty, and gastrointestinal symptoms may begin. |
| More Intense Withdrawal | First several days | Physical discomfort, muscle aches, gastrointestinal symptoms, anxiety, cravings, and disrupted sleep may become more noticeable. |
| Symptoms Begin to Ease | Several days to a week or longer | Acute physical symptoms may gradually improve, although the experience varies considerably between individuals. |
| Lingering Symptoms | Following the acute withdrawal period | Some individuals may continue experiencing cravings, sleep difficulties, anxiety, low mood, or other psychological symptoms after the more immediate physical symptoms improve. |
As the National Institute on Drug Abuse (NIDA) explains, research on kratom and its compounds is still developing. Reports of withdrawal have been documented among people who use kratom regularly, but there is not enough evidence to assign every person using concentrated 7-OH the same predictable withdrawal course.
For someone who has been using 7-OH regularly, particularly in high amounts or alongside alcohol, benzodiazepines, opioids, or other substances, a professional assessment can help determine the safest way to stop and whether medically supervised detox is appropriate.
Treatment for 7-OH Addiction at Desert Willow Wellness
If you’re struggling with 7-OH or kratom use, treatment should be based on your individual symptoms, substance use history, overall health, and whether other substances or mental health concerns are involved. At Desert Willow Wellness, treatment may begin with medically supervised detox and continue into structured residential care, allowing the focus to shift from managing withdrawal to understanding patterns of use and building a stronger foundation for continued recovery.
Medical Detox
For individuals who have developed physical dependence, the first step may be safely reducing or stopping 7-OH while managing withdrawal symptoms. Our medical detox program provides 24/7 monitoring and supportive care, with medications used when clinically appropriate based on each person’s symptoms and medical needs.
Residential Treatment
After stabilization, clients may transition into residential treatment, where care becomes focused on the behavioral, emotional, and psychological aspects of substance use. Individual therapy, group sessions, case management, structured daily programming, and relapse prevention help clients better understand the factors contributing to their substance use and develop healthier ways of responding to triggers and stress.
Dual Diagnosis Care
Some people may use 7-OH or kratom while also experiencing anxiety, depression, trauma-related symptoms, or other mental health concerns. DWW’s dual diagnosis treatment addresses substance use and co-occurring mental health conditions together when appropriate, rather than treating each concern in isolation.
Holistic Therapies
Recovery involves more than managing withdrawal symptoms. DWW incorporates holistic approaches including mindfulness, meditation, recreation, wellness activities, and other supportive practices that can complement clinical treatment and help clients develop healthier ways of managing stress and emotions.
Evidence-Based Treatment
Treatment also incorporates evidence-based therapeutic approaches that address the thoughts, behaviors, triggers, and patterns associated with substance use. A systematic review concluded with evidence supporting its use as part of substance use disorder treatment. While this research is not specific to 7-OH or kratom, it supports the broader use of Cognitive Behavioral Therapy (CBT) in addiction treatment.
The Benefits of 7-OH Addiction Treatment at Desert Willow Wellness
The benefits of 7-OH Addiction Treatment can extend beyond managing the immediate symptoms of withdrawal. At Desert Willow Wellness, treatment is individualized to help clients stabilize, understand the patterns contributing to their substance use, develop healthier coping strategies, and prepare for continued recovery.
Reduces Cravings & Withdrawal
During medical detox, clinical monitoring and appropriate medication support can help manage withdrawal symptoms and improve comfort as the body adjusts to reducing or stopping 7-OH. Treatment can also begin addressing cravings and other factors that may make it difficult to stop using.
Supports Relapse Prevention
Rather than focusing only on stopping 7-OH use, treatment helps clients identify triggers, understand patterns of substance use, develop coping strategies, and create a plan for managing challenges after treatment. These skills can support relapse prevention as recovery continues.
Personalized Care
No two people develop substance-related problems in exactly the same way. Treatment planning considers each client’s substance use history, physical and mental health needs, current circumstances, and goals so care can be adjusted as those needs change.
Whole-Person Healing
Substance use can affect physical health, emotional well-being, relationships, routines, and overall quality of life. Combining evidence-based treatment with supportive wellness and holistic practices allows recovery to address more than withdrawal symptoms alone.
When to Seek Help
You don’t have to wait until 7-OH or kratom use has caused a major crisis before seeking support. If you’re concerned about your use or finding it increasingly difficult to stop, a professional assessment can help determine what level of care may be appropriate.
It may be time to seek help if:
- You feel physically or emotionally dependent on 7-OH or kratom
- You experience withdrawal symptoms when you reduce, delay, or stop using
- You’ve tried to cut back or stop but haven’t been able to
- You’re using larger amounts or using more frequently than you intended
- Cravings or thoughts about your next dose are becoming difficult to control
- Your substance use is affecting your mental health, relationships, work, or daily responsibilities
- You continue using despite recognizing negative consequences
- You’re worried about stopping on your own or aren’t sure how to do so safely
Start Recovery at Desert Willow Wellness
If 7-OH or kratom use has become difficult to control, you don’t have to navigate the next steps alone. Desert Willow Wellness provides individualized medical detox and residential treatment for substance use disorders, including support for co-occurring mental health concerns when appropriate.
Our team can help assess your needs, manage withdrawal safely, and develop a treatment plan focused on stabilization, understanding the factors contributing to substance use, and preparing for continued recovery.
Reach out to Desert Willow Wellness today to speak with our admissions team and learn more about treatment options for 7-OH or kratom dependence.
Looking for immediate admission?
References that will show on the website:
- An Evaluation of Cognitive Behavioral Therapy for Substance Use Disorder: A Systematic Review and Application of the Society of Clinical Psychology Criteria for Empirically Supported Treatments – PubMed
- Kratom | National Institute on Drug Abuse (NIDA)
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7923387/
- https://www.nature.com/articles/s41598-020-76119-w
- https://www.aol.com/news/rfk-jr-launches-crackdown-kratom-182520929.html
- Feds launch crackdown on kratom byproduct
- 7-Hydroxymitragynin (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat
- FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers | FDA
- Kratom exposures among older adults reported to U.S. poison centers, 2014-2019 – PubMedDEA to
- Temporarily Schedule 7-OH and Related Substances to Protect Public Safety